Official Launch of Journal of Cellular Gene Therapy & Regenerative Medicine: Inviting Global Scholars to Build a Sustainable Future Research Platform

We are proud to announce the official launch of Journal of Cellular Gene Therapy & Regenerative Medicine (JCGTRM), a peer-reviewed open-access journal dedicated to bridging molecular innovation, therapeutic engineering, and clinical translation in gene and cell therapy. The journal focuses on the full innovation continuum—from molecular mechanisms and vector design to regulatory practice and real-world application—uniting scientists, clinicians, engineers, and policy specialists.

 

JCGTRM will be published quarterly, featuring original research, reviews, and case studies that advance safe, effective, and scalable advanced therapies. We aim to build a leading interdisciplinary platform that accelerates global progress in regenerative health solutions.

 

Call for Editorial Board Members

We are actively recruiting passionate and accomplished scholars to join our Editorial Board. Ideal candidates possess expertise in gene/cell therapy, regenerative medicine, or related fields, with a track record of academic excellence and peer review experience.

 

Call for Papers

Submissions are now open for our inaugural issue. We welcome original research articles, comprehensive reviews, and clinical translation studies aligned with our scope. Submit your manuscript to contribute to the future of regenerative medicine.

 

The call for papers for the inaugural issue is now open! We look forward to receiving your innovative research contributions.

 

Submission System: https://journal.bytran-pub.com/index.php/jcgtrm/about/submission

Author Guidelines and template: https://journal.bytran-pub.com/index.php/jcgtrm/ForAuthors

Editorial Office: editorial_jcgtrm@bytran-pub.com